If CTCF was the target gene of 16q22.1 LOH in ductal carcinoma of the breast, then we would predict that a large proportion of ductal tumours might show marked or complete loss of its expression compared with other histological types and/or with the normal parenchymal tissues. Here, CTCF is linked to breast ductal adenocarcinoma.